Published in Brain Pathol on January 01, 1999
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev (2000) 5.71
Simian virus 40 infection of humans. J Virol (2003) 1.71
Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci U S A (1999) 1.15
Simian virus 40 in humans. Infect Agent Cancer (2007) 1.09
Simian virus 40 transformation, malignant mesothelioma and brain tumors. Expert Rev Respir Med (2011) 0.96
Human immunoglobulin G levels of viruses and associated glioma risk. Cancer Causes Control (2011) 0.90
Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients. Infect Agent Cancer (2010) 0.85
Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40. Orphanet J Rare Dis (2006) 0.84
Chronic viral infection and primary central nervous system malignancy. J Neuroimmune Pharmacol (2010) 0.84
Viral carcinogenesis: factors inducing DNA damage and virus integration. Cancers (Basel) (2014) 0.82
Is SV40 a tumorigenic human pathogen? Brain Pathol (1999) 0.75
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol (1999) 4.25
Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol (1996) 4.18
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
Left-right asymmetry and kinesin superfamily protein KIF3A: new insights in determination of laterality and mesoderm induction by kif3A-/- mice analysis. J Cell Biol (1999) 3.14
Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol (1997) 2.40
Hans-Joachim Scherer (1906-1945), pioneer in glioma research. Brain Pathol (1999) 2.20
A detachable balloon procedure for a traumatic internal carotid-internal jugular fistula: report of a case. Neurosurgery (1990) 2.10
The treatment gap in epilepsy: the current situation and ways forward. Epilepsia (2001) 2.10
The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol (1986) 2.07
The complete nucleotide sequence of the ilvGMEDA operon of Escherichia coli K-12. Nucleic Acids Res (1987) 2.04
Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci (1996) 1.91
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae. Microbiol Rev (1996) 1.77
Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS). Acta Neuropathol (1985) 1.76
Carcinogenicity of N-methyl-N-nitrosourea: possible role of excision repair of O6-methylguanine from DNA. J Natl Cancer Inst (1974) 1.76
Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component. Acta Neuropathol (1991) 1.72
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis (2001) 1.71
Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res (1997) 1.71
Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol (1999) 1.66
A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol (1990) 1.64
Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas. Lab Invest (2000) 1.59
Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res (2001) 1.58
Genetic profile of gliosarcomas. Am J Pathol (2000) 1.57
Near-real-time guidance using intraoperative magnetic resonance imaging for radical evacuation of hypertensive hematomas in the basal ganglia. Neurosurgery (2000) 1.57
Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol (1993) 1.57
Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest (2001) 1.54
PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol (1998) 1.52
Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci (2000) 1.48
Reversibility of ischemic brain damage. Arch Neurol (1973) 1.48
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res (1992) 1.48
SURVEY AND SUMMARY: Saccharomyces cerevisiae basic helix-loop-helix proteins regulate diverse biological processes. Nucleic Acids Res (2000) 1.45
Dynamic changes during evacuation of a left temporal abscess in open MRI: technical case report. Neuroradiology (2002) 1.45
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest (1994) 1.45
p53 mutations in nonastrocytic human brain tumors. Cancer Res (1991) 1.42
Intracranial dermoid cysts: variations of radiological and clinical features. Acta Neurochir (Wien) (2008) 1.41
[Surfactant replacement therapy: a multicentric trial comparing two dosage approaches]. J Pediatr (Rio J) (2003) 1.40
APC mutations in sporadic medulloblastomas. Am J Pathol (2000) 1.40
Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg (1988) 1.40
Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol (1993) 1.39
More about: cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst (2000) 1.39
Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol (1990) 1.38
Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg (1992) 1.36
Persistent inhibition of protein synthesis precedes delayed neuronal death in postischemic gerbil hippocampus. Acta Neuropathol (1986) 1.35
Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res (2000) 1.35
Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog (1993) 1.32
Cerebellar hemorrhage after supratentorial craniotomy--report of three cases. Neurol Med Chir (Tokyo) (1990) 1.31
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. Br J Cancer (2009) 1.30
Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res (1998) 1.29
Autoregulated expression of the yeast INO2 and INO4 helix-loop-helix activator genes effects cooperative regulation on their target genes. Mol Cell Biol (1995) 1.28
Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (1989) 1.27
p14ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol (2001) 1.27
Demonstration of carcinogenicity in F344 rats of 2-amino-3-methyl-imidazo[4,5-f]quinoline from broiled sardine, fried beef and beef extract. Gan (1984) 1.26
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene (2003) 1.26
Results of microsurgical extra-intracranial arterial bypass in the treatment of cerebral ischemia. Neurosurgery (1978) 1.25
Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis (1984) 1.24
Chemical carcinogenesis in the nervous system. Preferential accumulation of O6-methylguanine in rat brain deoxyribonucleic acid during repetitive administration of N-methyl-N-nitrosourea. Biochem J (1975) 1.24
Intraoperative validation of functional magnetic resonance imaging and cortical reorganization patterns in patients with brain tumors involving the primary motor cortex. J Neurosurg (1999) 1.24
Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) (1992) 1.24
Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res (1989) 1.23
Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol (1995) 1.23
The yeast UME6 gene is required for both negative and positive transcriptional regulation of phospholipid biosynthetic gene expression. Nucleic Acids Res (1996) 1.22
A pleiotropic phospholipid biosynthetic regulatory mutation in Saccharomyces cerevisiae is allelic to sin3 (sdi1, ume4, rpd1). Genetics (1994) 1.21
The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery (1996) 1.20
Transvenous embolization of dural caroticocavernous fistulae: technical considerations. Neuroradiology (1993) 1.20
Neuroimaging of cerebellar liponeurocytoma. Case report. J Neurosurg (2001) 1.19
Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas. Acta Neuropathol (1997) 1.19
Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol (1997) 1.19
Differentiation in the medulloblastoma. A histological and immunohistochemical study. Acta Neuropathol (1987) 1.19
Human islet isolation for autologous transplantation: comparison of yield and function using SERVA/Nordmark versus Roche enzymes. Am J Transplant (2009) 1.18
Evaluation of islet transplantation from non-heart beating donors. Am J Transplant (2006) 1.18
Growth rate of human pituitary adenomas. J Neurosurg (1987) 1.17